The tale of a person and a peptide: Wylie W. Vale Jr. and the role of corticotropin-releasing factor in the stress response

Journal of Chemical Neuroanatomy

Volumn 54, Issue , 2013, Pages 1-4

  Bittencourt, Jackson C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Corticotropin releasing factor; Corticotropin releasing factor receptors; Corticotropin releasing factor binding protein; Stress response; Urocortin; Wylie Vale

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NEUROPEPTIDE;

ARTICLE; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PUBLICATION; STRESS;

ACTH; ADRENOCORTICOTROPIC HORMONE; CORTICOTROPIN-RELEASING FACTOR; CORTICOTROPIN-RELEASING FACTOR RECEPTOR TYPE 1; CORTICOTROPIN-RELEASING FACTOR RECEPTOR TYPE 2; CORTICOTROPIN-RELEASING FACTOR RECEPTORS; CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN; CRF; CRFR1; CRFR2; HPA; HYPOTHALAMIC-PITUITARY-ADRENAL; LABORATORIES FOR PEPTIDE BIOLOGY (CLAYTON FOUNDATION, SALK INSTITUTE FOR BIOLOGICAL STUDIES); LABORATORY OF NEURONAL STRUCTURE AND FUNCTION; LNSF; PBL; STRESS RESPONSE; UROCORTIN; WYLIE VALE;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; ENDOCRINOLOGY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEUROLOGY; STRESS, PHYSIOLOGICAL; UNITED STATES;

EID: 84888434922     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2013.04.005     Document Type: Article

References (26)

1. Bale T.L., Chen A. Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit. Endocrinology 2012, 153:2556-2561.
2. Bale T.L., Hoshijima M., Gu Y., Dalton N., Anderson K.R., Lee K.F., Rivier J., Chien K.R., Vale W.W., Peterson K.L. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3697-3702.
3. Bale T.L., Picetti R., Contarino A., Koob G.F., Vale W.W., Lee K.F. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. Journal of Neuroscience 2002, 22:193-199.
4. Bilezikjian L.M. In memoriam: Wylie Vale Jr., Ph.D. (1941-2012). Endocrinology 2012, 153:2533-2535.
5. Bloom F.E., Battenberg E.L., Rivier J., Vale W. Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus. Regulatory Peptides 1982, 4:43-48.
6. Chen A., Perrin M., Brar B., Li C., Jamieson P., Digruccio M., Lewis K., Vale W. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Molecular Endocrinology 2005, 19:441-458.
7. Chen R., Lewis K.A., Perrin M.H., Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:8967-8971.
8. De Souza E.B., Insel T.R., Perrin M.H., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. Journal of Neuroscience 1985, 5:3189-3203.
9. Flandreau E.I., Bourke C.H., Ressler K.J., Vale W.W., Nemeroff C.B., Owens M.J. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala. Psychoneuroendocrinology 2012.
10. Guillemin R. Remembering Wylie Vale 2012, Roger & Lucienne Guillemin Foundation, http://guilleminfoundation.smugmug.com/Family/wylie-vale-salk-chemist/20913175_5TVW9m#!i=1938918178&k=9ZptWkP.
11. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., Vale W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:7570-7575.
12. Li C., Chen P., Vaughan J., Blount A., Chen A., Jamieson P.M., Rivier J., Smith M.S., Vale W. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology 2003, 144:3216-3224.
13. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344.
14. Neufeld-Cohen A., Tsoory M.M., Evans A.K., Getselter D., Gil S., Lowry C.A., Vale W.W., Chen A. A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:19020-19025.
15. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:2969-2973.
16. Perrin M.H., Donaldson C.J., Chen R., Lewis K.A., Vale W.W. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993, 133:3058-3061.
17. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:4192-4196.
18. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:2843-2848.
19. Rivier J., Rivier C., Vale W. Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science 1984, 224:889-891.
20. Rivier J., Spiess J., Vale W. Characterization of rat hypothalamic corticotropin-releasing factor. Proceedings of the National Academy of Sciences of the United States of America 1983, 80:4851-4855.
21. Smith S.M., Vale W.W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues in Clinical Neuroscience 2006, 8:383-395.
22. Sutton R.E., Koob G.F., Le Moal M., Rivier J., Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature 1982, 297:331-333.
23. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
24. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
25. Vale W.W. Studies on the Control of Thyrotropin Secretion, Physiology 1968, Baylor University College of Medicine, Huston.
26. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.